Therapeutic Alert: Interleukin-6 inhibitors (tocilizumab or sarilumab) for critically ill patients with COVID-19 pneumonia (adults)
10 February 2021
The MHRA have released a therapeutic alert regarding Interleukin-6 inhibitors alongside interim policies for tocilizumab and sarilumab.
ENDS